Invivyd, Inc. Faces Delisting Concerns
Ticker: IVVD · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Invivyd's on the chopping block - might get delisted soon.
AI Summary
Invivyd, Inc. (formerly Adagio Therapeutics, Inc.) filed an 8-K on April 25, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of April 21, 2025. The company, incorporated in Delaware, is in the biological products sector and is headquartered in Waltham, MA.
Why It Matters
This filing indicates potential issues with Invivyd's compliance with stock exchange listing requirements, which could impact its stock's tradability and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial health.
Key Numbers
- 001-40703 — Commission File Number (Identifies the company's filing with the SEC.)
- 85-1403134 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former Name
- April 21, 2025 (date) — Earliest event reported
- April 25, 2025 (date) — Filing date
- 001-40703 (company) — Commission File Number
- 85-1403134 (company) — IRS Employer Identification No.
- 1601 Trapelo Road, Suite 178 (address) — Principal Executive Offices
- Waltham, MA (location) — Principal Executive Offices City and State
FAQ
What specific listing rule or standard has Invivyd, Inc. failed to satisfy?
The filing does not specify the exact listing rule or standard that Invivyd, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy has been issued.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 21, 2025.
What was Invivyd, Inc.'s former name?
Invivyd, Inc.'s former name was Adagio Therapeutics, Inc.
Where are Invivyd, Inc.'s principal executive offices located?
Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What is the filing date of this 8-K report?
This 8-K report was filed on April 25, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding Invivyd, Inc. (IVVD).